CNTB

Connect Biopharma Holdings
CNTB

25 hedge funds and large institutions have $16.4M invested in Connect Biopharma Holdings in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 10 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$541K
2
+$22.5K
3
+$19.7K
4
JP Morgan Chase
JP Morgan Chase
New York
+$3.39K
5
SA
SRH Advisors
Kansas
+$1.44K

Top Sellers

1
-$637K
2
-$551K
3
-$481K
4
Citadel Advisors
Citadel Advisors
Florida
-$357K
5
DCM
DAFNA Capital Management
California
-$218K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$9.02M
2
$1.84M
3
$1.65M
4
$954K
5
$792K
6
$771K
7
$581K
8
$283K
9
$277K
10
$107K
11
$50K
12
$35K
13
$24K
14
$21K
15
$17K
16
$10K
17
$4K
18
$2K
19
$1K
20
$1K
21
$1K
22
$333
23
–
24
–
25
–
1
2